Research output per year
Research output per year
Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 1/04/16 → 31/01/22 |
Funding
- Other: £1,465,256.00
Research output
- 3 Article
-
Early (Days 1–4) post-treatment serum hCG level changes predict single-dose methotrexate treatment success in tubal ectopic pregnancy
Mackenzie, S. C., Moakes, C. A., Doust, A. M., Mol, B. W., Duncan, W. C., Tong, S., Horne, A. W. & Whitaker, L. H. R., 13 May 2023, (E-pub ahead of print) In: Human Reproduction.Research output: Contribution to journal › Article › peer-review
Open AccessFile -
Combination of gefitinib and methotrexate to treat tubal ectopic pregnancy (GEM3): a multicentre, randomised, double-blind, placebo-controlled trial
GEM3 Collaborative, 1 Feb 2023, (E-pub ahead of print) In: The Lancet.Research output: Contribution to journal › Article › peer-review
Open AccessFile -
A multi-centre, double-blind, placebo-controlled, randomised trial of combination methotrexate and gefitinib versus methotrexate alone to treat tubal ectopic pregnancies (GEM3): trial protocol
May, J., Duncan, C., Mol, B., Bhattacharya, S., Daniels, J., Middleton, L., Hewitt, C., Coomarasamy, A., Jurkovic, D., Bourne, T., Bottomley, C., Peace-gadsby, A., Doust, A., Tong, S. & Horne, A. W., 20 Nov 2018, In: Trials. 19, 1Research output: Contribution to journal › Article › peer-review
Open AccessFile
Activities
- 11 Invited talk
-
The management of ectopic pregnancy: past, present and future
Andrew Horne (Invited speaker)
2 Nov 2017Activity: Academic talk or presentation types › Invited talk
-
NICE guidelines on endometriosis explained
Andrew Horne (Invited speaker)
18 Oct 2017 → 21 Oct 2017Activity: Academic talk or presentation types › Invited talk
-
Engaging patients and clinicians to prioritise endometriosis research
Andrew Horne (Invited speaker)
5 Oct 2017Activity: Academic talk or presentation types › Invited talk